{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:48:10Z","timestamp":1794084490732,"version":"4.8.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8132","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,9,17]]},"DOI":"10.1038\/s41586-026-10843-7","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:02:34Z","timestamp":1785942154000},"page":"789-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A dependency map enhanced with next-generation 3D cancer models"],"prefix":"10.1038","volume":"657","author":[{"given":"James V.","family":"Neiswender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8862-178X","authenticated-orcid":false,"given":"Samuel","family":"Maffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Brenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"ElHarouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejie","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-1225","authenticated-orcid":false,"given":"Isabella","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-4420","authenticated-orcid":false,"given":"Kirsty","family":"Wienand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Inam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tate","family":"Bertea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-8079","authenticated-orcid":false,"given":"Ashley","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4730-6232","authenticated-orcid":false,"given":"Megan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5271-4306","authenticated-orcid":false,"given":"Evan","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Villafranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Shanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3019-5738","authenticated-orcid":false,"given":"Nia","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Shadmany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-7577","authenticated-orcid":false,"given":"Sarah J.","family":"Wie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3834-8297","authenticated-orcid":false,"given":"Konnor","family":"Yunghans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8536-6460","authenticated-orcid":false,"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-1081","authenticated-orcid":false,"given":"Philip","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-8517","authenticated-orcid":false,"given":"Ross M.","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-2303","authenticated-orcid":false,"given":"Guadalupe","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-4084","authenticated-orcid":false,"given":"Caitlin E.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Touat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Sai","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9841-5085","authenticated-orcid":false,"given":"Sonja","family":"Herter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5087-0587","authenticated-orcid":false,"given":"Zoe Hoffmann","family":"Kamrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-5285","authenticated-orcid":false,"given":"Julien","family":"Dilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Khuan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy A.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossef","family":"Baidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-9514","authenticated-orcid":false,"given":"Daniel D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-2621","authenticated-orcid":false,"given":"Sonam","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-9918","authenticated-orcid":false,"given":"Srivatsan","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-3609","authenticated-orcid":false,"given":"Rameen","family":"Beroukhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-4965","authenticated-orcid":false,"given":"David L.","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-4758","authenticated-orcid":false,"given":"Adam J.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-1838","authenticated-orcid":false,"given":"Peter K.","family":"Sorger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0171-3884","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-9459","authenticated-orcid":false,"given":"Sarah J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-6923","authenticated-orcid":false,"given":"Steffi","family":"Oesterreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-514X","authenticated-orcid":false,"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3259-2226","authenticated-orcid":false,"given":"Himisha","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-6336","authenticated-orcid":false,"given":"Jesse S.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen-Yi","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-861X","authenticated-orcid":false,"given":"David E.","family":"Root","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-9791","authenticated-orcid":false,"given":"William C.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0701-6203","authenticated-orcid":false,"given":"Andrew J.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7733-600X","authenticated-orcid":false,"given":"Keith L.","family":"Ligon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3634-9576","authenticated-orcid":false,"given":"Joshua M.","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-6154","authenticated-orcid":false,"given":"Tsukasa","family":"Shibue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2857-4685","authenticated-orcid":false,"given":"Francisca","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"10843_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1158\/2159-8290.CD-23-0467","volume":"14","author":"SP Suehnholz","year":"2024","unstructured":"Suehnholz, S. P. et al. Quantifying the expanding landscape of clinical actionability for patients with cancer. Cancer Discov. 14, 49\u201365 (2024).","journal-title":"Cancer Discov."},{"key":"10843_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","volume":"25","author":"R Arafeh","year":"2025","unstructured":"Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C. & Vazquez, F. The present and future of the Cancer Dependency Map. Nat. Rev. Cancer 25, 59\u201373 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"10843_CR3","doi-asserted-by":"publisher","unstructured":"Waarts, M. R., Stonestrom, A. J., Park, Y. C. & Levine, R. L. Targeting mutations in cancer. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI154943 (2022).","DOI":"10.1172\/JCI154943"},{"key":"10843_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/d41586-021-00182-0","volume":"589","author":"JS Boehm","year":"2021","unstructured":"Boehm, J. S. et al. Cancer research needs a better map. Nature 589, 514\u2013516 (2021).","journal-title":"Nature"},{"key":"10843_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/2472555217697434","volume":"22","author":"M Selby","year":"2017","unstructured":"Selby, M. et al. 3D models of the NCI60 cell lines for screening oncology compounds. SLAS Discov. 22, 473\u2013483 (2017).","journal-title":"SLAS Discov."},{"key":"10843_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952\u2013955 (2019).","journal-title":"Science"},{"key":"10843_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee, J. et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391\u2013403 (2006).","journal-title":"Cancer Cell"},{"key":"10843_CR8","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan, S. et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 184, 6119\u20136137 (2021).","journal-title":"Cell"},{"key":"10843_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04495-z","volume":"9","author":"L Puca","year":"2018","unstructured":"Puca, L. et al. Patient derived organoids to model rare prostate cancer phenotypes. Nat. Commun. 9, 2404 (2018).","journal-title":"Nat. Commun."},{"key":"10843_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe1505","volume":"376","author":"F Tang","year":"2022","unstructured":"Tang, F. et al. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 376, eabe1505 (2022).","journal-title":"Science"},{"key":"10843_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/0008-5472.CAN-21-2807","volume":"82","author":"S Bhatia","year":"2022","unstructured":"Bhatia, S. et al. Patient-derived triple-negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics. Cancer Res. 82, 1174\u20131192 (2022).","journal-title":"Cancer Res."},{"key":"10843_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen, B. et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell 185, 563\u2013575 (2022).","journal-title":"Cell"},{"key":"10843_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416 (2018).","journal-title":"Cell"},{"key":"10843_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson, D. R. et al. Integrative clinical genomics of metastatic cancer. Nature 548, 297\u2013303 (2017).","journal-title":"Nature"},{"key":"10843_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20294-x","volume":"12","author":"A Warren","year":"2021","unstructured":"Warren, A. et al. Global computational alignment of tumor and cell line transcriptional profiles. Nat. Commun. 12, 22 (2021).","journal-title":"Nat. Commun."},{"key":"10843_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.3954","volume":"21","author":"H Gao","year":"2015","unstructured":"Gao, H. et al. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat. Med. 21, 1318\u20131325 (2015).","journal-title":"Nat. Med."},{"key":"10843_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1541-7786.MCR-07-0280","volume":"6","author":"A Li","year":"2008","unstructured":"Li, A. et al. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol. Cancer Res. 6, 21\u201330 (2008).","journal-title":"Mol. Cancer Res."},{"key":"10843_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176\u2013187 (2014).","journal-title":"Cell"},{"key":"10843_CR19","doi-asserted-by":"publisher","unstructured":"ElHarouni, D. et al. A compendium of next-generation patient-derived models for diverse cancers. Nature https:\/\/doi.org\/10.1038\/s41586-026-10806-y (2026).","DOI":"10.1038\/s41586-026-10806-y"},{"key":"10843_CR20","doi-asserted-by":"publisher","unstructured":"Herranz-Ors, C. et al. A tumour-derived organoid biobank maps cancer gene dependencies. Nature https:\/\/doi.org\/10.1038\/s41586-026-10830-y (2026).","DOI":"10.1038\/s41586-026-10830-y"},{"key":"10843_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41587-020-0600-6","volume":"39","author":"PC DeWeirdt","year":"2021","unstructured":"DeWeirdt, P. C. et al. Optimization of AsCas12a for combinatorial genetic screens in human cells. Nat. Biotechnol. 39, 94\u2013104 (2021).","journal-title":"Nat. Biotechnol."},{"key":"10843_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-020-2099-x","volume":"580","author":"K Han","year":"2020","unstructured":"Han, K. et al. CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities. Nature 580, 136\u2013141 (2020).","journal-title":"Nature"},{"key":"10843_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02540-7","volume":"22","author":"JM Dempster","year":"2021","unstructured":"Dempster, J. M. et al. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 22, 343 (2021).","journal-title":"Genome Biol."},{"key":"10843_CR24","unstructured":"DepMap Consortium. DepMap: The Cancer Dependency Map Project at Broad Institute. Broad Institute https:\/\/depmap.org\/portal\/ (2026)."},{"key":"10843_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-03020-w","volume":"24","author":"JM Krill-Burger","year":"2023","unstructured":"Krill-Burger, J. M. et al. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR\u2013Cas9 knockout is pan-lethal. Genome Biol. 24, 192 (2023).","journal-title":"Genome Biol."},{"key":"10843_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 (2017).","journal-title":"Cell"},{"key":"10843_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2023.12.016","volume":"42","author":"C Pacini","year":"2024","unstructured":"Pacini, C. et al. A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization. Cancer Cell 42, 301\u2013316 (2024).","journal-title":"Cancer Cell"},{"key":"10843_CR28","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/emboj.2011.259","volume":"30","author":"CV Lefave","year":"2011","unstructured":"Lefave, C. V. et al. Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas: hnRNPH-dependent splicing switch in gliomas. EMBO J. 30, 4084\u20134097 (2011).","journal-title":"EMBO J."},{"key":"10843_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/NEN.0b013e3181ca4767","volume":"69","author":"T Elsir","year":"2010","unstructured":"Elsir, T., Eriksson, A., Orrego, A., Lindstr\u00f6m, M. S. & Nist\u00e9r, M. Expression of PROX1 is a common feature of high-grade malignant astrocytic gliomas. J. Neuropathol. Exp. Neurol. 69, 129\u2013138 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10843_CR30","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.3390\/cancers12123869","volume":"12","author":"E Campaner","year":"2020","unstructured":"Campaner, E. et al. Breast cancer organoids model patient-specific response to drug treatment. Cancers 12, 3869 (2020).","journal-title":"Cancers"},{"key":"10843_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen, K. P. et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat. Cancer 3, 232\u2013250 (2022).","journal-title":"Nat. Cancer"},{"key":"10843_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02173-2","volume":"21","author":"M Dede","year":"2020","unstructured":"Dede, M., McLaughlin, M., Kim, E. & Hart, T. Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome Biol. 21, 262 (2020).","journal-title":"Genome Biol."},{"key":"10843_CR33","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-021-00967-z","volume":"53","author":"T Ito","year":"2021","unstructured":"Ito, T. et al. Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nat. Genet. 53, 1664\u20131672 (2021).","journal-title":"Nat. Genet."},{"key":"10843_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","volume":"867","author":"MA Isgr\u00f2","year":"2015","unstructured":"Isgr\u00f2, M. A., Bottoni, P. & Scatena, R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv. Exp. Med. Biol. 867, 125\u2013143 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"10843_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature11331","volume":"488","author":"FL Muller","year":"2012","unstructured":"Muller, F. L. et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 488, 337\u2013342 (2012).","journal-title":"Nature"},{"key":"10843_CR36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1158\/1535-7163.MCT-24-0213","volume":"24","author":"S Lu","year":"2025","unstructured":"Lu, S. et al. Targeting monounsaturated fatty acid metabolism for radiosensitization of KRAS mutant 3D lung cancer models. Mol. Cancer Ther. 24, 920\u2013930 (2025).","journal-title":"Mol. Cancer Ther."},{"key":"10843_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023).","journal-title":"Nature"},{"key":"10843_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"ML Suv\u00e0","year":"2014","unstructured":"Suv\u00e0, M. L. et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157, 580\u2013594 (2014).","journal-title":"Cell"},{"key":"10843_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-021-01151-4","volume":"9","author":"Y Kim","year":"2021","unstructured":"Kim, Y. et al. Perspective of mesenchymal transformation in glioblastoma. Acta Neuropathol. Commun. 9, 50 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"10843_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0273-7","volume":"16","author":"CR Oliva","year":"2018","unstructured":"Oliva, C. R. et al. IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2\/IGF-1R signaling. Cell Commun. Signal. 16, 61 (2018).","journal-title":"Cell Commun. Signal."},{"key":"10843_CR41","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462\u2013477 (2013).","journal-title":"Cell"},{"key":"10843_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.celrep.2019.03.047","volume":"27","author":"G MacLeod","year":"2019","unstructured":"MacLeod, G. et al. Genome-wide CRISPR\u2013Cas9 screens expose genetic vulnerabilities and mechanisms of temozolomide sensitivity in glioblastoma stem cells. Cell Rep. 27, 971\u2013986 (2019).","journal-title":"Cell Rep."},{"key":"10843_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34536-7","volume":"13","author":"CE Mills","year":"2022","unstructured":"Mills, C. E. et al. Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop. Nat. Commun. 13, 6918 (2022).","journal-title":"Nat. Commun."},{"key":"10843_CR44","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-24-0562","volume":"30","author":"AM Nasser","year":"2024","unstructured":"Nasser, A. M. et al. CDKN2A\/B homozygous deletion sensitizes IDH-mutant glioma to CDK4\/6 inhibition. Clin. Cancer Res. 30, 2996\u20133005 (2024).","journal-title":"Clin. Cancer Res."},{"key":"10843_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110 (2010).","journal-title":"Cancer Cell"},{"key":"10843_CR46","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"10843_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-025-03844-8","volume":"26","author":"IA Boyle","year":"2025","unstructured":"Boyle, I. A. et al. Natural language processing of gene descriptions for overrepresentation analysis with GeneTEA. Genome Biol. 26, 376 (2025).","journal-title":"Genome Biol."},{"key":"10843_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.cellbio.042308.113344","volume":"25","author":"AM Zorn","year":"2009","unstructured":"Zorn, A. M. & Wells, J. M. Vertebrate endoderm development and organ formation. Annu. Rev. Cell Dev. Biol. 25, 221\u2013251 (2009).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10843_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nm.4219","volume":"23","author":"Z Steinhart","year":"2017","unstructured":"Steinhart, Z. et al. Genome-wide CRISPR screens reveal a Wnt\u2013FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors. Nat. Med. 23, 60\u201368 (2017).","journal-title":"Nat. Med."},{"key":"10843_CR50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","volume":"22","author":"T Seino","year":"2018","unstructured":"Seino, T. et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell 22, 454\u2013467 (2018).","journal-title":"Cell Stem Cell"},{"key":"10843_CR51","doi-asserted-by":"publisher","first-page":"508","DOI":"10.21037\/tlcr.2017.06.10","volume":"6","author":"YJ Cha","year":"2017","unstructured":"Cha, Y. J. & Shim, H. S. Biology of invasive mucinous adenocarcinoma of the lung. Transl. Lung Cancer Res. 6, 508\u2013512 (2017).","journal-title":"Transl. Lung Cancer Res."},{"key":"10843_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/his.13993","volume":"76","author":"Y Mikami","year":"2020","unstructured":"Mikami, Y. Gastric-type mucinous carcinoma of the cervix and its precursors\u2014historical overview: history of GAS. Histopathology 76, 102\u2013111 (2020).","journal-title":"Histopathology"},{"key":"10843_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega, F. et al. Oncogenic signaling pathways in The Cancer Genome Atlas. Cell 173, 321\u2013337 (2018).","journal-title":"Cell"},{"key":"10843_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm2593","volume":"10","author":"B Geiger","year":"2009","unstructured":"Geiger, B., Spatz, J. P. & Bershadsky, A. D. Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell Biol. 10, 21\u201333 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10843_CR55","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.1073\/pnas.0904227106","volume":"106","author":"T Shibue","year":"2009","unstructured":"Shibue, T. & Weinberg, R. A. Integrin \u03b21-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl Acad. Sci. USA 106, 10290\u201310295 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10843_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature10826","volume":"482","author":"CT Leung","year":"2012","unstructured":"Leung, C. T. & Brugge, J. S. Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature 482, 410\u2013413 (2012).","journal-title":"Nature"},{"key":"10843_CR57","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1158\/0008-5472.CAN-19-1165","volume":"79","author":"T Shibue","year":"2019","unstructured":"Shibue, T., Reinhardt, F. & Weinberg, R. A. Syndecan-mediated ligation of ECM proteins triggers proliferative arrest of disseminated tumor cells. Cancer Res. 79, 5944\u20135957 (2019).","journal-title":"Cancer Res."},{"key":"10843_CR58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"The Cancer Genome Atlas Network.","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"10843_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"The Cancer Genome Atlas Research Network","year":"2017","unstructured":"The Cancer Genome Atlas Research Network Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32, 185\u2013203 (2017).","journal-title":"Cancer Cell"},{"key":"10843_CR60","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/cancers13051147","volume":"13","author":"N Olympios","year":"2021","unstructured":"Olympios, N. et al. TERT promoter alterations in glioblastoma: a systematic review. Cancers 13, 1147 (2021).","journal-title":"Cancers"},{"key":"10843_CR61","doi-asserted-by":"publisher","unstructured":"Benjamin, D. et al. Calling somatic SNVs and Indels with Mutect2. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/861054 (2019).","DOI":"10.1101\/861054"},{"key":"10843_CR62","unstructured":"van der Auwera, G. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly Media, 2020)."},{"key":"10843_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13029-016-0060-z","volume":"11","author":"M Riester","year":"2016","unstructured":"Riester, M. et al. PureCN: copy number calling and SNV classification using targeted short read sequencing. Source Code Biol. Med. 11, 13 (2016).","journal-title":"Source Code Biol. Med."},{"key":"10843_CR64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41586-020-03114-6","volume":"590","author":"Y Cohen-Sharir","year":"2021","unstructured":"Cohen-Sharir, Y. et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature 590, 486\u2013491 (2021).","journal-title":"Nature"},{"key":"10843_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30196-9","volume":"13","author":"R Li","year":"2022","unstructured":"Li, R. et al. Comparative optimization of combinatorial CRISPR screens. Nat. Commun. 13, 2469 (2022).","journal-title":"Nat. Commun."},{"key":"10843_CR66","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/s41596-023-00835-6","volume":"18","author":"T Abid","year":"2023","unstructured":"Abid, T. et al. Genome-wide pooled CRISPR screening in neurospheres. Nat. Protoc. 18, 2014\u20132031 (2023).","journal-title":"Nat. Protoc."},{"key":"10843_CR67","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR\u2013Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779\u20131784 (2017).","journal-title":"Nat. Genet."},{"key":"10843_CR68","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","volume":"568","author":"FM Behan","year":"2019","unstructured":"Behan, F. M. et al. Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens. Nature 568, 511\u2013516 (2019).","journal-title":"Nature"},{"key":"10843_CR69","doi-asserted-by":"publisher","unstructured":"Dempster, J. M. et al. Extracting biological insights from the Project Achilles genome-scale CRISPR screens in cancer cell lines. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/720243 (2019).","DOI":"10.1101\/720243"},{"key":"10843_CR70","doi-asserted-by":"publisher","first-page":"733","DOI":"10.15252\/msb.20145216","volume":"10","author":"T Hart","year":"2014","unstructured":"Hart, T., Brown, K. R., Sircoulomb, F., Rottapel, R. & Moffat, J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol. 10, 733 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"10843_CR71","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.aac7557","volume":"350","author":"VA Blomen","year":"2015","unstructured":"Blomen, V. A. et al. Gene essentiality and synthetic lethality in haploid human cells. Science 350, 1092\u20131096 (2015).","journal-title":"Science"},{"key":"10843_CR72","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.3853","volume":"13","author":"M Hafner","year":"2016","unstructured":"Hafner, M., Niepel, M., Chung, M. & Sorger, P. K. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat. Methods 13, 521\u2013527 (2016).","journal-title":"Nat. Methods"},{"key":"10843_CR73","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell 33, 721\u2013735 (2018).","journal-title":"Cancer Cell"},{"key":"10843_CR74","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1523\/JNEUROSCI.0346-04.2004","volume":"24","author":"Q Li","year":"2004","unstructured":"Li, Q. et al. A syntaxin 1, G\u03b1o, and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J. Neurosci. 24, 4070\u20134081 (2004).","journal-title":"J. Neurosci."},{"key":"10843_CR75","doi-asserted-by":"publisher","unstructured":"Broad DepMap. Data files associated with A Dependency Map Enhanced with Next-Generation 3D Cancer Models. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.29472362 (2026).","DOI":"10.6084\/m9.figshare.29472362"},{"key":"10843_CR76","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385 (2018).","journal-title":"Cell"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10843-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10843-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10843-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:37:57Z","timestamp":1789558677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10843-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":76,"journal-issue":{"issue":"8132","published-print":{"date-parts":[[2026,9,17]]}},"alternative-id":["10843"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10843-7","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.S.W. reports research funding from Microsoft and compensation from Engine Ventures and AbbVie for consulting or speaking unrelated to this work. S.R. receives research support from Microsoft and holds equity in Amgen. Y.C. receives shares and royalties from ORIC Pharmaceuticals, research grants from Foghorn Therapeutics and fees from Belharra Therapeutics. D.E.R. receives research funding from members of the Functional Genomics Consortium (Abbvie, BMS, Jannsen and Merck) and is a director of Addgene. W.C.H. is a consultant for Thermo\u00a0Fisher, Solasta Ventures, KSQ Therapeutics, Frontier Medicines, Jubilant Therapeutics, Serinus Biosciences, Kestral Therapeutics, Crane Biotherapeutics, Weaver Therapeutics, Recursion Pharma and Perceptive. C.D.C. serves as a paid consultant for Droplet Biosciences. K.L.L. receives consulting fees from Travera, BMS, Blaze Bioscience, Integragen, L.E.K. Consulting, and Servier; holds equity in Travera; and receives research support to DFCI from BMS and Lilly. J.M.D. is a consultant for Jumble Therapeutics and owns equity. F.V. receives research support from the Dependency Map Consortium, Riva Therapeutics, Bristol Myers Squibb, Merck, Astrazeneca and Illumina. F.V. has consulted for GSK, is an advisor and holds equity in Riva Therapeutics and Z Prime Therapeutics and is a co-founder and holds equity in Jumble Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}